Clinical Trial Update: Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing vonoprazan to omeprazole as empiric therapy for GERD without alarm features was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Omeprazole (Omeprazole)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: St. Luke's Medical Center, Philippines | Conditions: GERD, Gastro Esophageal Reflux | Phase 4 | Status: TERMINATED